Pharming PHAR
NASDAQ PHAR
$13.22 +0.06 (+0.46%)
At close: Nov 10, 2026 · 4:00 PM EST

Pharming (PHAR) Current Deferred Tax Liability (2021 - 2024)

Updated

Analysis

Pharming (PHAR) Current Deferred Tax Liability (2021 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Pharming 927.62 Mn 229.29 Mn 102.20
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 30.54 Mn
Dec 31, 2023 29.76 Mn
Dec 31, 2022 22.97 Mn
Dec 31, 2021 21.22 Mn
API Access

Pharming Current Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=curent-deferred-tax-liability&ticker=PHAR&period=max&api_key=YOUR_API_KEY